Cleared Traditional

K200959 - Biolox® delta Ceramic Heads, Biolox® delta Option Ceramic Heads MR Labeling

K200959 is an FDA 510(k) clearance for Biolox delta Ceramic Heads, manufactured by Biomet UK, Ltd.. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K200959 · Biomet UK, Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
110d
Days
Class 2
Risk

K200959 is an FDA 510(k) clearance for the Biolox® delta Ceramic Heads, Biolox® delta Option Ceramic Heads MR Labeling. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Biomet UK, Ltd. (Brigend, GB). The FDA issued a Cleared decision on July 29, 2020 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biomet UK, Ltd. devices

FDA 510(k) Submission Details - K200959

510(k) Number K200959 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2020
Decision Date July 29, 2020
Days to Decision 110 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 122d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 506
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K200959.
Spartan Hip Stem
K192883 · Signature Orthopaedics Pty, Ltd. · Aug 2020
Corin Optimized Positioning System (OPS) Femoral
K193545 · Corin USA · Aug 2020
Cemented Origin Hip Stem
K201951 · Signature Orthopaedics Pty, Ltd. · Jul 2020
Cemented TSI Hip Stem
K192024 · Signature Orthopaedics Pty, Ltd. · Jun 2020
M-Vizion Femoral Revision System Extension
K191816 · Medacta International S.A. · Apr 2020
PROFEMUR GLADIATOR Thin HA Classic Hip Stem with Collar
K200007 · Microport Orthopedics, Inc. · Apr 2020